59
ST ELEVATION MYOCARDIAL INFARCTION (STEMI) ANTEROSEPTAL WALL ONSET >24 HOURS KILLIP II Case Report Cardiology Department Medical Faculty Hasanuddin University Sekar Tiarin S C 111 09 807 Supervisor: dr. Pendrik Tandean, SpPD-KKV. FINASIM HASANUDDIN UNIVERSITY MAKASSAR 2015

Stemi

Embed Size (px)

DESCRIPTION

ppt

Citation preview

Slide 1

ST Elevation Myocardial Infarction (STEMI) anteroseptal wallONSET >24 HOURSKILLIP II

Case Report

Cardiology DepartmentMedical FacultyHasanuddin UniversitySekar Tiarin SC 111 09 807Supervisor: dr. Pendrik Tandean, SpPD-KKV. FINASIMHASANUDDIN UNIVERSITYMAKASSAR2015NameMr. IBGenderMaleAge62 years oldAddressMakassarMedical Record No.555485Date of Admission15-6- 2015Patients IdentityChief complain : Chest pain on left sidePresent illness history : The chest pain felt about 5 days before he was admitted to Wahidin Sudirohusodo hospital, occurred suddenly and lasted for approximately 30 minutes. The pain is described like dull heavy feeling on the chest and radiates to the left hand. The chest pain didnt relieve by taking a rest. ANAMNESISNausea (-), vomiting (-) Cold Sweat (+)Cough ( - ), Shortness of breath ( - ), Palpitation ( - )Dizziness (-), headache (-) Urination = normalDefecation = normal

PREVIOUS ILLNESS HISTORYHistory of heart disease ( - )History of hypertension (-)History of diabetes melitus is unknownHistory of smoking (+) since 10 years oldFamily history of heart disease (-)RISK FACTORModified Risk FactorHistory of smoking (+) since 10 years oldNon-modified risk factor:Gender : maleAge : 62 year old

General status:Moderate illness/well nourished/composmentis

Vital StatusTekanan darah: 120/80 mmHgNadi: 60 x/menitPernapasan: 20 x/menitSuhu: 36,6C

Physical ExaminationHead:NormochepalicEye:Anemis (-), Icteric (-)Pupil:Equal, round, diameter 2,5 mm, reactive to lightNares:Appearent is normalMouth:No cyanosisNeck:JVP R+2 cmH20, no lymphadenopathy, no thyroid enlargementLungInspection: Equal expension bilaterallyPalpation: No tenderness, no mass palpablePercussion: Normal resonance bilaterallyAuscultation:Breath Sounds: VesicularAdventitious breath sound: Ronchi -/- , wheezing -/-

Physical ExaminationPhysical ExaminationCardiac ExaminationInspection: Ictus cordis was invisiblePalpation : Ictus cordis was palpable in ICS V about 1 finger from lateral of medioclavicularis sinistra line, Thrill (-)Percussion: Right heart border in right parasternalis line, left heart border in left midclavicle line ICS V.Auscultation : Heart Sound I/II pure regular, murmur(-). Abdominal Inspection: Flat, following breath movementAuscultation: Peristaltic sound (+), normalPalpation: Liver and spleen are unpalpablePercussion: shifting dullness (-)Extremities Oedema pretibial -/-Oedema dorsum pedis -/- Cyanosis (-), Clubbing finggers (-)Physical ExaminationECG

Rhythm : sinus, regulerQRS Rate : Heart rate 55 bpm Axis : NormoaxisP Wave : normalPR Interval : normalQRS Complex : menyempitST Segment: ST elevasi V1-V3T Wave: T nverted V1-V3 Conclusion : HR 55 bpm STEMI anteroseptal

ECG INTERPRETATIONFoto thoraxKesan

Cardiomegaly disertai dilatatio et elongatio aortaeTanda2 bendungan paruAtherosclerosis aortae

Laboratory FindingsHasilNilai NormalRBC6.32.106/mm3(4,5 - 6,5).106/mm3HGB19,2 g/dL14 - 18 g/dLWBC16,47.103/mm3(4 - 10).103/mm3PLT248.103/mm3(150 - 500).103/mm3PT12,2 kontrol 11,410-14INR1,17APTT24,422-30GDS75 mg/dl< 200 mg/dLCK121,00 U/L< 190 U/LCK-MB29,7 U/L< 25 U/LTroponin I55u/dlLDL87 u/dl24 Jam KILLIP IITherapyO2 2-4 L/menit/nasalIVFD NaCl 0,9%/500 cc/24 jamArixtra 2,5 mg/24jam/scAnti platelet: Clopidogrel 75 mg loading 1x4 tab, maintenance 0-0-1, Aspilet 80 mg loading 1 x 2 tab, maintenance 0-1-0Anti kolesterol : Simvastatin 20 mg 0 - 0 1Farsorbid 10 mg/24 jam/oralRamipril 5mg 0-2-0Nitrat 0,5 mg (bila nyeri dada)Bisoprolol 1,25 mg/24 jamLaxadin syr 0-0-2 C

ManagementPlanningECHOCARDIOGRAPHYACUTE CORONARY SYndromeDEFINITIONSAcute coronary syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. describe a group of conditions resulting from acute myocardial ischemia (insufficient blood flow to heart muscle) ranging from unstable angina(increasing, unpredictable chest pain) to myocardial infarction (heart attack).

Acute CoronarySyndromeTextUnstable AnginaTextTextNSTEMITextSTEMICLASSIFICATIONANATOMY

American Heart Association: http://watchlearnlive.heart.orgPATHOPHYSIOLOGY

American Heart Association: http://watchlearnlive.heart.org

American Heart Association: http://watchlearnlive.heart.org

American Heart Association: http://watchlearnlive.heart.org

American Heart Association: http://watchlearnlive.heart.org

American Heart Association: http://watchlearnlive.heart.org

American Heart Association: http://watchlearnlive.heart.org Unstable AnginaSTEMI NSTEMINon occlusive thrombus

Non specific ECG

Normal cardiac enzymes

Occluding thrombus sufficient to cause tissue damage & mild myocardial necrosis

ST depression +/- T wave inversion on ECG

Elevated cardiac enzymes

Complete thrombus occlusion

ST elevations on ECG or new LBBB

Elevated cardiac enzymes

More severe symptomsGender and Age Men, increased risk after age 45 Women, increased risk after age 55Family History CAD diagnosed before age 55 in father or brother CAD disease diagnosed before age 65 in mother or sisterNon- Modifiable

Modifiable

Smoking Hypertension Diabetes Mellitus Dyslipidemia Obesity Lack of physical activityRISK FACTORSDIAGNOSIS OF ACSAt least 2 of the following Ischemic symptoms Diagnostic ECG changes Serum cardiac marker elevations

DIAGNOSIS OF ACSIschemic symptoms Prolonged pain (usually >20 mins) constricting, crushing, squeezing Usually retrosternal location, radiating to left chest, left arm; can be epigastric Dyspnea Diaphoresis Palpitations Nausea/vomiting Light headedness Sense of impending doom

DIAGNOSIS OF ACS

At least 2 of the following Ischemic symptoms Diagnostic ECG changes Serum cardiac marker elevations

At least 2 of the following Ischemic symptoms Diagnostic ECG changes Serum cardiac marker elevations

Troponin T CK-MB CK Myoglobin

DIAGNOSIS OF ACSRISK SCORE FOR ACSTIMI Risk Score for STEMIHistorical Age 65-74 >/= 752 points3 points DM/HTN or Angina1 pointExam SBP < 1003 points HR > 1002 points Killip II-IV2 points Weight < 67 kg1 pointPresentation Anterior STE or LBBB1 point Time to rx > 4 hrs1 point Risk Score = Total(0-14)Risk ScoreOdds of death by 30D*00.1 (0.1-0.2)10.3 (0.2-0.3)20.4 (0.3-0.5)30.7 (0.6-0.9)41.2 (1.0-1.5)52.2 (1.9-2.6)63.0 (2.5-3.6)74.8 (3.8-6.1)85.8 (4.2-7.8)>88.8 (6.3-12)* referenced to average mortality (95% confidence intervals)Bed RestDietOxygen (2-4L/mnt)Anti platelet therapy : Aspirin 162-325mg chewed immediately and 81-162 mg continued indefinitely.Clopidogrel 300-600mg loading dose and 75mg daily continued for at least 14 days and up to 12 monthsNitroglycerin 0.4 mg SL tablets every 3-5 min up to 3 times; if effect is not sustained, can continue with an IV drip of 50mg in 250mL Dextrose 5%.Initial Treatment 2013 ACC/AHA Guideline STEMI37Morphine 2-5mg iv Q5-30minFibrinolytic therapy:a) Streptokinase 1.5million units iv b) Tenecteplase 0.5mg/kg body weight ivAnticoagulation therapy:a) Low Molecular Weight Heparins ( Fondaparinux) 2.5mg/24hrs/sc for up to 8 days post-MI.StatinsSimvastatin 20mg qdInitial Treatment 2013 ACC/AHA Guideline STEMI38ClassDescriptionMortality Rate (%)INo clinical signs of heart failure6IIRales or crackles in the lungs, an S3, and elevated jugular venous pressure17IIIAcute pulmonary edema30 - 40IVCardiogenic shock or hypotension (systolic BP < 90 mmHg), and evidence of peripheral vasoconstriction60 80KILLIP CLASSIFICATIONPROGNOSIS Smoking cessation Blood pressure control (less than 140/90 mmHg, or less than 130/80 mmHg in patients with diabetes or chronic kidney disease) Lipid management (LDL-C level substantially less than 100 mg per dL; nonHDL-C level less than 130 mg per dL in patients with triglyceride levels 200 mg per dL or greater) Physical activity (30 minutes at least five days per week)SECONDARY PREVENTIONS FOR PATIENTS WITH STEMI Weight management (BMI 18.5 to 24.9 kg per m2; waist circumference less than 40 inches in men, less than 35 inches in women) Diabetes management (A1C less than 7 percent) Antiplatelet and anticoagulant therapy Renin-angiotensin-aldosterone system blocker therapySECONDARY PREVENTIONS FOR PATIENTS WITH STEMI

THANK YOU DISCUSSIONACUTE CORONARY SYNDROME(ST SEGMENT ElevationMyocardial Infarction)Definition Acute myocardial infarction (AMI) is an irreversible necrosis of heart muscle due to prolonged ischemia, which is suddenly happened.Imbalance in oxygen supply and demand, which is most often caused by plaque rupture with thrombus formation in a coronary vessel, resulting in an acute reduction of blood supply to a portion of the myocardium.

PATHOPHYSIOLOGY

Occurs when coronary blood flow decreases abruptly after a thrombotic occlusion of a coronary artery previously affected by atherosclerosis.

In most cases, infarction occurs when an atherosclerotic plaque fissures, ruptures, or ulcerates

PATHOPHYSIOLOGY

American Heart Association: http://watchlearnlive.heart.org

American Heart Association: http://watchlearnlive.heart.org

American Heart Association: http://watchlearnlive.heart.org

American Heart Association: http://watchlearnlive.heart.org

American Heart Association: http://watchlearnlive.heart.org

American Heart Association: http://watchlearnlive.heart.orgGender and Age Men, increased risk > age 45 Women, increased risk > age 55Family History CAD diagnosed before age 55 in father or brother CAD disease diagnosed before age 65 in mother or sisterNon-Modifiable

Modifiable

Smoking Hypertension Diabetes Mellitus Dyslipidemia Obesity Lack of physical activityRISK FACTORS53

MANAGEMENT

5757KILLIP CLASSIFICATION

ClassDescriptionMortality Rate (%)Ino clinical signs of heart failure6IIrales or crackles in the lungs, an S3, and elevated jugular venous pressure17IIIacute pulmonary edema30 - 40IVcardiogenic shock or hypotension (systolic BP < 90 mmHg), and evidence of peripheral vasoconstriction60 80THANK YOU